Article info
Genetics
Pathogenic variants in the healthy elderly: unique ethical and practical challenges
- Correspondence to Dr Paul Lacaze, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, The Alfred Centre, 99 Commercial Road, Melbourne, VIC 3004, Australia; paul.lacaze{at}monash.edu
Citation
Pathogenic variants in the healthy elderly: unique ethical and practical challenges
Publication history
- Received September 28, 2016
- Revised December 20, 2016
- Accepted February 6, 2017
- First published March 24, 2017.
Online issue publication
September 28, 2017
Article Versions
- Previous version (28 September 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Other content recommended for you
- Protective lipid-lowering variants in healthy older individuals without coronary heart disease
- Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disorders
- Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort study
- Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada
- Clinical application of fetal genome-wide sequencing during pregnancy: position statement of the Canadian College of Medical Geneticists
- Guideline for feedback of individual genetic research findings for genomics research in Africa
- Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panel
- AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol
- Structural Aberrations with Secondary Implications (SASIs): consensus recommendations for reporting of cancer susceptibility genes identified during analysis of Copy Number Variants (CNVs)
- Taking it to the bank: the ethical management of individual findings arising in secondary research